Related Experiment Video
Updated: Jun 15, 2026
07:43
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on
Françoise Galland1, Ludovic Lacroix, Patrick Saulnier
1Hôpital de Bicêtre, France.
Endocrine-Related Cancer
|March 16, 2010
Summary
Invasive non-functioning pituitary adenomas (NFPAs) show distinct gene expression profiles. Myosin 5A (MYO5A) protein levels were higher in invasive tumors, suggesting it as a potential marker for invasiveness.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Non-functioning pituitary adenomas (NFPAs) can exhibit local invasiveness.
- Identifying markers for invasiveness is crucial for guiding patient management and radiotherapy decisions.
Purpose of the Study:
- To investigate if invasive NFPAs have a specific gene expression profile compared to non-invasive tumors.
- To identify potential molecular markers for predicting NFPA invasiveness.
Main Methods:
- Pangenomic analysis using microarrays on 40 NFPAs (22 invasive, 18 non-invasive).
- Differential gene expression analysis to identify candidate genes.
- Quantitative reverse transcription PCR (qRT-PCR) to validate gene expression.
- Immunohistochemistry to assess protein expression of candidate markers.
Main Results:
- Gene expression analysis revealed 346 differentially expressed genes between invasive and non-invasive NFPAs.
- Four genes (IGFBP5, MYO5A, FLT3, NFE2L1) showed confirmed overexpression in invasive tumors via qRT-PCR.
- Myosin 5A (MYO5A) protein expression was significantly higher in invasive NFPAs.
Conclusions:
- A molecular signature can differentiate invasive from non-invasive NFPAs.
- Myosin 5A (MYO5A) shows promise as a potential biomarker for pituitary tumor invasiveness.